Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Thore, Thiesler"'
Autor:
Mateja Condic, Thore Thiesler, Christian Staerk, Niklas Klümper, Jörg Ellinger, Eva K. Egger, Kirsten Kübler, Glen Kristiansen, Alexander Mustea, Damian J. Ralser
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Vulvar squamous cell carcinoma (VSCC) is an uncommon gynecologic malignancy but with an increasing incidence in recent years. Etiologically, VSCC is classified into two subtypes: HPV-dependent and HPV-independent. Localized VSCC i
Externí odkaz:
https://doaj.org/article/57fe9adfda1943c699a45879061aa79b
Autor:
Damian Ralser, Mateja Condic, Niklas Klümper, Jörg Ellinger, Christian Staerk, Eva Egger, Glen Kristiansen, Alexander Mustea, Thore Thiesler
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:2417-2424
Purpose N6-methyladenosine (m6A) is the most frequent type of messenger RNA (mRNA) modification and is implicated in diverse physiological processes. The procedure of m6A RNA modification is regulated by a dynamic interaction of writers (METTL3, METT
Autor:
Mateja Condic, Eva K. Egger, Niklas Klümper, Glen Kristiansen, Alexander Mustea, Thore Thiesler, Damian J. Ralser
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Vulvar squamous cell carcinoma (VSCC) is a rare malignancy of the female genital tract with increasing incidence rates. Etiologically, HPV-dependent and HPV-independent VSCC are distinguished. Surgical treatment and/or radiotherapy represent
Autor:
Eva K. Egger, Mateja Condic, Damian J. Ralser, Milka Marinova, Alexander Mustea, Florian Recker, Glen Kristiansen, Thore Thiesler
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1046
Volume 15
Issue 4
Pages: 1046
Background: To analyze clinical, pathological and immunohistochemical correlates of survival in vaginal cancer patients. Methods: Retrospective analysis of primary vaginal cancer patients, treated at the Department of Gynecology and Gynecological Onc
Autor:
Mateja Condic, Damian J. Ralser, Niklas Klümper, Jörg Ellinger, Maryam Qureischi, Eva K. Egger, Glen Kristiansen, Alexander Mustea, Thore Thiesler
Publikováno v:
International journal of molecular sciences. 23(13)
There is growing scientific evidence for the crucial role of post-transcriptional RNA modifications in carcinogenesis, progression, metastasis, and drug resistance across various cancer entities. N6-methyladenosine (m6A) is the most abundant type of
Autor:
THOMAS HECKING, THORE THIESLER, JANINA HALBE, LUCIA OTTEN, FLORIAN RECKER, HEIDRUN GEVENSLEBEN, TIM MÜLLER, CYNTHIA SCHILLER, EVA K. EGGER, ROLF FIMMERS, MATTHIAS B. STOPE, GLEN KRISTIANSEN, ALEXANDER MUSTEA
Publikováno v:
Anticancer research. 42(3)
Endometrial carcinoma (EC) is one of the most common gynecological cancers in the Western Hemisphere. Nevertheless, there are not enough appropriate treatment options, especially for advanced stages. The immune checkpoint blockade represents a promis
Autor:
Mattis Bertlich, Tim Koppen, Izabela Tuleta, Friedrich Bootz, Thorsten Send, Mark Jakob, Thore Thiesler, K.W.G. Eichhorn
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 276:1969-1974
Sarcoidosis is a chronic disease, which predominantly affects the lung. Since sinonasal sarcoidosis is rare, little is known about the sarcoidosis manifestation at this site. Therefore, the aim of our study was to detect the prevalence of sinonasal s
Autor:
Stefan C. Müller, Thore Thiesler, Roland Vorreuther, Sabine Lubig, Glen Kristiansen, Norbert Leipner
Publikováno v:
Pathology. 50:298-304
This study aimed to investigate the prognostic value of a quantitative, detailed, yet practical analysis of perineural invasion in radical prostatectomy specimens in a high-risk prostate cancer cohort. A total of 114 patients with prostate cancer who
Autor:
D Bartmann, T. van Bremen, Thore Thiesler, A. Pantelis, Götz Schade, Friedrich Bootz, T Send, A. Charpentier
Publikováno v:
HNO. 67:952-954
Autor:
Kirsten Kübler, Thore Thiesler, Glen Kristiansen, Mateja Condic, Rolf Fimmers, Mignon-Denise Keyver-Paik, Thomas Hecking, Walther Kuhn, Andrea Rohr, Jean-Marc Lunkenheimer, Cynthia Schiller, TH Ayub, Jutta Kirfel
Publikováno v:
Oncotarget
Vulvar cancer is rare but incidence rates are increasing due to an aging population and higher frequencies of young women being affected. In locally advanced, metastatic or recurrent disease prognosis is poor and new treatment modalities are needed.